Stage IVB Cervical Cancer AJCC v6 and v7
5 clinical trials · Condition
◉ Watch Stage IVB Cervical Cancer AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer (NCT02921269) | National Cancer Institute (NCI) | 2017-03-10 |
| Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer (NCT03902379) | Rutgers, The State University of New Jersey | 2016-07-27 |
| Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer (NCT02257528) | National Cancer Institute (NCI) | 2015-05-18 |
| Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer (NCT01693783) | National Cancer Institute (NCI) | 2012-12-03 |
| Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer (NCT01281852) | National Cancer Institute (NCI) | 2011-03-14 |
Track Stage IVB Cervical Cancer AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.